`Patent 7,879,828
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APOTEX, INC.
`Petitioner
`
`v.
`
`WYETH LLC
`Patent Owner
`
`
`Case IPR2014-00115
`
`Patent 7,879,828
`
`SUBMISSION OF MANDATORY NOTICE INFORMATION
`PURSUANT TO 37 C.F.R. § 42.8(a)(2)
`
`Pursuant to 37 C.F.R. § 48.2(a)(2), Patent Owner Wyeth LLC submits the
`
`
`
`following mandatory notice information.
`
`
`
`
`
`Case IPR2014-00115
`Patent 7,879,828
`
`
`REAL PARTY-IN-INTEREST
`
`Wyeth LLC, a Delaware limited liability company having a place of
`
`business at 5 Giralda Farms, Madison, New Jersey 07940, is the owner of the
`
`entire interest in U.S. Patent No. 7,879,828 (“the ’828 patent”). PF PRISM, C.V.,
`
`a limited partnership (commanditaire vennootschap) organized and existing under
`
`the laws of the Netherlands and having offices at Blaak 40 basement, 3011 TA,
`
`Rotterdam, Netherlands, took an exclusive license in the ’828 patent. Thereafter,
`
`PF PRISM C.V. contributed its rights under the exclusive license to Pfizer
`
`Pharmaceuticals LLC, a Delaware limited liability company having a place of
`
`business at Bo. Carmelitas, Road 689, Km 1.9, Vega Baja, Puerto Rico 00693.
`
`Wyeth LLC, PF PRISM C.V., and Pfizer Pharmaceuticals LLC are wholly-owned,
`
`directly or indirectly, by Pfizer Inc., a publicly-traded company.
`
`
`
`2
`
`
`
`Case IPR2014-00115
`Patent 7,879,828
`
`
`RELATED MATTERS
`
`The following judicial and administrative matters could affect, or be affected
`
`by, a decision in this proceeding:
`
`• The ’828 patent has been asserted in the following litigation, which is
`
`currently pending: Pfizer Inc., et al. v. Fresenius Kabi USA, LLC, No.
`
`1:13-cv-01893-SLR (D. Del.).
`
`• There is also litigation pending in the United States District Court for
`
`the District of Delaware between the Petitioner and the Patent Owner
`
`arising from Petitioner’s submission of an Abbreviated New Drug
`
`Application to market a generic version of Pfizer’s drug Tygacil ®.
`
`Pfizer Inc., et al. v. Apotex Inc. and Apotex Corp., 1:13-cv-01613-
`
`SLR (D. Del.). The ’828 patent is not asserted in that case because
`
`Apotex did not assert pursuant to 21 U.S.C. § 355(b)(2)(A)(iv) that
`
`the ’828 patent was invalid or would not be infringed by the
`
`manufacture, use, or sale of the drug covered by Apotex’s
`
`Abbreviated New Drug Application.
`
`• Patent Application Number 13/011,164, which was filed on January
`
`21, 2011, is pending and claims the benefit of Application Number
`
`
`
`3
`
`
`
`Case IPR2014-00115
`Patent 7,879,828
`
`
`11/374,330, which is an application in the chain leading to issuance of
`
`the ’828 patent.
`
`
`
`4
`
`
`
`Case IPR2014-00115
`Patent 7,879,828
`
`
`LEAD AND BACK-UP COUNSEL
`
`
`
`Patent Owner Wyeth LLC designates the following lead and back-up
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Back-Up Counsel
`
`David Kiernan
`Reg. No. 43,714
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`202-434-5191 (Telephone)
`202-434-5029 (Facsimile)
`dkiernan@wc.com
`
`counsel:
`
`Lead Counsel
`
`
`
`
`
`
`Stanley E. Fisher
`
`Reg. No. 55,820
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`
`202-434-5289 (Telephone)
`202-434-5029 (Facsimile)
`sfisher@wc.com
`
`
`
`
`
`
`
`
`
`
`
`5
`
`
`
`Case IPR2014-00115
`Patent 7,879,828
`
`
`SERVICE INFORMATION
`
`(i)
`
`Electronic mail addresses:
`
`
`
`(ii) Postal mailing address:
`
`
`
`
`
`
`
`(iii) Hand-delivery address:
`
`(iv) Telephone Number:
`
`
`
`Facsimile number:
`
`
`
`(v)
`
`
`
`
`
`
`
`
`
`
`
`
`sfisher@wc.com
`dkiernan@wc.com
`jonathanwilliams@wc.com
`mkidd@wc.com
`jeff.rennecker@pfizer.com
`robyn.popeck@pfizer.com
`
`Stanley E. Fisher
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`
`Same as above
`
`202-434-5289
`
`202-434-5029
`
`6
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2014-00115
`Patent 7,879,828
`
`
`CONCLUSION
`
`Patent Owner Wyeth LLC believes that this submission fulfills the
`
`requirements of 37 C.F.R. § 42.8(a)(2). Please contact the undersigned counsel if
`
`any additional information is required.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Stanley E. Fisher/
`Stanley E. Fisher
`Lead Attorney for Wyeth LLC
`Reg. No. 55,820
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`
`Phone: 202-434-5289
`
`
`
`7
`
`
`
`Dated: November 22, 2013
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2014-00115
`Patent 7,879,828
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the above-captioned Submission of
`
`
`
`Mandatory Notice Information Pursuant to 37 C.F.R. § 42.8(a)(2) was served on
`
`November 22, 2013, by filing this document through the Patent Review Processing
`
`System as well as delivering a copy via electronic mail upon the following
`
`attorneys of record for the Petitioner:
`
`Kenneth J. Burchfiel
`kburchfiel@sughrue.com
`Travis B. Ribar
`tribar@sughrue.com
`Sughrue Mion, PLLC
`2100 Pennsylvania Ave., N.W.
`Washington, DC 20037
`
`
`
`Dated: November 22, 2013
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`/Stanley E. Fisher/
`Stanley E. Fisher
`Lead Attorney for Wyeth LLC
`Reg. No. 55,820
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`
`Phone: 202-434-5289
`
`
`
`8